开云app官网登录入口网页版-官方正版

#TRAP#

21篇内容 | 1285人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2005381, encodeId=ba5e200538109, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=Alzheimer's & Dementia：如何做到在2025年预防阿尔茨海默病：目标-风险-AD-预防（TRAP）战略简析, objectType=article, longId=217381, objectId=13e721e38191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13e721e38191, replyNumber=0, likeNumber=69, createdTime=2022-04-07, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13e721e38191, moduleTitle=Alzheimer's & Dementia：如何做到在2025年预防阿尔茨海默病：目标-风险-AD-预防（TRAP）战略简析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=13e721e38191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005380, encodeId=b345200538036, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=Circulation：ADCY9基因型对Anacetrapib临床疗效的影响, objectType=article, longId=179691, objectId=27ae1e9691de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27ae1e9691de, replyNumber=0, likeNumber=66, createdTime=2020-01-12, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27ae1e9691de, moduleTitle=Circulation：ADCY9基因型对Anacetrapib临床疗效的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=27ae1e9691de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005379, encodeId=c59b20053e9e6, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=Cell Signal：Trapidil通过上调骨形成蛋白的信号传导诱导骨生成, objectType=article, longId=141379, objectId=89bd1413e902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89bd1413e902, replyNumber=0, likeNumber=67, createdTime=2018-12-23, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89bd1413e902, moduleTitle=Cell Signal：Trapidil通过上调骨形成蛋白的信号传导诱导骨生成, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=89bd1413e902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005378, encodeId=c63120053e8a2, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=Pharmacogn Mag：Trapa natans可有效对抗抗结核药物引起的肝毒性, objectType=article, longId=138121, objectId=5d21138121af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d21138121af, replyNumber=0, likeNumber=65, createdTime=2019-04-15, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d21138121af, moduleTitle=Pharmacogn Mag：Trapa natans可有效对抗抗结核药物引起的肝毒性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5d21138121af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005375, encodeId=57b720053e56d, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=NEJM：Anacetrapib治疗动脉粥样硬化并不会增加冠脉疾病的发生风险, objectType=article, longId=114843, objectId=df9f11484357, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df9f11484357, replyNumber=0, likeNumber=77, createdTime=2018-01-03, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df9f11484357, moduleTitle=NEJM：Anacetrapib治疗动脉粥样硬化并不会增加冠脉疾病的发生风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=df9f11484357)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005377, encodeId=c14320053e7ac, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=J Periodontol：牙周炎患者中抗蛋白酶TRAPIN-2与促炎细胞因子呈负相关, objectType=article, longId=130453, objectId=1eac13045332, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eac13045332, replyNumber=0, likeNumber=83, createdTime=2018-06-08, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eac13045332, moduleTitle=J Periodontol：牙周炎患者中抗蛋白酶TRAPIN-2与促炎细胞因子呈负相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1eac13045332)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005370, encodeId=e3f520053e043, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=“坏”胆固醇的克星：新药Anacetrapib将问世！, objectType=article, longId=103707, objectId=20cc103e0708, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20cc103e0708, replyNumber=0, likeNumber=65, createdTime=2017-11-07, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20cc103e0708, moduleTitle=“坏”胆固醇的克星：新药Anacetrapib将问世！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=20cc103e0708)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005369, encodeId=4bc120053698f, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=NEJM：Evacetrapib不能有效降低患者心血管事件风险, objectType=article, longId=99077, objectId=93db990e7c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93db990e7c5, replyNumber=0, likeNumber=48, createdTime=2018-03-17, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93db990e7c5, moduleTitle=NEJM：Evacetrapib不能有效降低患者心血管事件风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=93db990e7c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005372, encodeId=6d2420053e29f, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=【ESC 2017】REVEAL：Anacetrapib可减少高危患者严重心血管事件的发生, objectType=article, longId=111403, objectId=69f7111403a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69f7111403a9, replyNumber=0, likeNumber=48, createdTime=2018-06-26, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69f7111403a9, moduleTitle=【ESC 2017】REVEAL：Anacetrapib可减少高危患者严重心血管事件的发生, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=69f7111403a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005376, encodeId=349e20053e6fc, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=【AHA 2017】重要实验结果公布：Anacetrapib对新发糖尿病发病及糖尿病患者血管事件的影响, objectType=article, longId=120663, objectId=c2811206633c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2811206633c, replyNumber=0, likeNumber=70, createdTime=2018-03-05, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2811206633c, moduleTitle=【AHA 2017】重要实验结果公布：Anacetrapib对新发糖尿病发病及糖尿病患者血管事件的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c2811206633c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005374, encodeId=890420053e401, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=NEJM：Anacetrapib对动脉粥样硬化性血管疾病的治疗效果, objectType=article, longId=114840, objectId=e1501148404e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1501148404e, replyNumber=0, likeNumber=53, createdTime=2018-08-03, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1501148404e, moduleTitle=NEJM：Anacetrapib对动脉粥样硬化性血管疾病的治疗效果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e1501148404e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005371, encodeId=3e2620053e12f, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=J Periodontol：抗蛋白酶预警器Trappin-2与牙周炎患者促炎症因子的负相关性研究, objectType=article, longId=108310, objectId=40a310831084, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40a310831084, replyNumber=0, likeNumber=58, createdTime=2017-12-21, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40a310831084, moduleTitle=J Periodontol：抗蛋白酶预警器Trappin-2与牙周炎患者促炎症因子的负相关性研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=40a310831084)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005373, encodeId=6f2120053e3a6, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=【ESC 2017】REVEAL研究表明他汀联合anacetrapib可降低高危患者心血管事件的发生, objectType=article, longId=111412, objectId=2c14111412a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c14111412a4, replyNumber=0, likeNumber=71, createdTime=2018-06-14, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c14111412a4, moduleTitle=【ESC 2017】REVEAL研究表明他汀联合anacetrapib可降低高危患者心血管事件的发生, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2c14111412a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005368, encodeId=db822005368de, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=新一代肌钙蛋白T试验能一小时快速诊断心肌梗死（TRAPID-AMI 研究）, objectType=article, longId=62539, objectId=9fbd625396f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fbd625396f, replyNumber=0, likeNumber=64, createdTime=2016-10-24, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fbd625396f, moduleTitle=新一代肌钙蛋白T试验能一小时快速诊断心肌梗死（TRAPID-AMI 研究）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9fbd625396f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005367, encodeId=88e4200536eab, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=JCI：TRAP技术捕捉急性肾损伤的早期迹象, objectType=article, longId=37927, objectId=16573e9272d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16573e9272d, replyNumber=0, likeNumber=57, createdTime=2015-03-08, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16573e9272d, moduleTitle=JCI：TRAP技术捕捉急性肾损伤的早期迹象, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=16573e9272d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005366, encodeId=ca7b200536635, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=NEJM：Dalcetrapib对近期有急性冠脉综合征的稳定性冠心病患者的疗效, objectType=article, longId=12345, objectId=a5d51234571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5d51234571, replyNumber=0, likeNumber=76, createdTime=2013-01-07, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5d51234571, moduleTitle=NEJM：Dalcetrapib对近期有急性冠脉综合征的稳定性冠心病患者的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a5d51234571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005363, encodeId=325b2005363fa, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=J Neurosci：spectraplakins蛋白或为治疗神经变性疾病提供新思路, objectType=article, longId=8139, objectId=4d338139a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d338139a3, replyNumber=0, likeNumber=86, createdTime=2013-02-21, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d338139a3, moduleTitle=J Neurosci：spectraplakins蛋白或为治疗神经变性疾病提供新思路, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4d338139a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005362, encodeId=fb4f200536264, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=赛诺菲公司发布Zaltrap治疗肿瘤报告：喜忧参半, objectType=article, longId=5423, objectId=d2a654239c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2a654239c, replyNumber=0, likeNumber=66, createdTime=2012-12-31, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2a654239c, moduleTitle=赛诺菲公司发布Zaltrap治疗肿瘤报告：喜忧参半, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d2a654239c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005364, encodeId=1647200536498, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=赛诺菲及Regeneron抗癌药Zaltrap获FDA批准用于结直肠癌治疗, objectType=article, longId=8590, objectId=583585906e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=583585906e, replyNumber=0, likeNumber=0, createdTime=2013-06-25, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=583585906e, moduleTitle=赛诺菲及Regeneron抗癌药Zaltrap获FDA批准用于结直肠癌治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=583585906e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2005361, encodeId=83702005361c2, content=<a href='/topic/show?id=1b141e76998' target=_blank style='color:#2F92EE;'>#TRAP#</a>, objectTitle=赛诺菲抗癌药Zaltrap 前列腺癌III期研究败北, objectType=article, longId=5417, objectId=4fc7541ee2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fc7541ee2, replyNumber=0, likeNumber=79, createdTime=2012-06-09, rootId=0, userName=xue8602, userId=d139492, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fc7541ee2, moduleTitle=赛诺菲抗癌药Zaltrap 前列腺癌III期研究败北, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4fc7541ee2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

TRAP

2020-05-29

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

Alzheimer's & Dementia：如何做到在2025年预防阿尔茨海默病：目标-风险-AD-预防（TRAP）战略简析

2022-04-07

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

Circulation：ADCY9基因型对Anacetrapib临床疗效的影响

2020-01-12

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

Cell Signal：Trapidil通过上调骨形成蛋白的信号传导诱导骨生成

2018-12-23

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

Pharmacogn Mag：Trapa natans可有效对抗抗结核药物引起的肝毒性

2019-04-15

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

NEJM：Anacetrapib治疗动脉粥样硬化并不会增加冠脉疾病的发生风险

2018-01-03

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

J Periodontol：牙周炎患者中抗蛋白酶TRAPIN-2与促炎细胞因子呈负相关

2018-06-08

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

“坏”胆固醇的克星：新药Anacetrapib将问世！

2017-11-07

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

NEJM：Evacetrapib不能有效降低患者心血管事件风险

2018-03-17

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

【ESC 2017】REVEAL：Anacetrapib可减少高危患者严重心血管事件的发生

2018-06-26

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

【AHA 2017】重要实验结果公布：Anacetrapib对新发糖尿病发病及糖尿病患者血管事件的影响

2018-03-05

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

NEJM：Anacetrapib对动脉粥样硬化性血管疾病的治疗效果

2018-08-03

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

J Periodontol：抗蛋白酶预警器Trappin-2与牙周炎患者促炎症因子的负相关性研究

2017-12-21

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

【ESC 2017】REVEAL研究表明他汀联合anacetrapib可降低高危患者心血管事件的发生

2018-06-14

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

新一代肌钙蛋白T试验能一小时快速诊断心肌梗死（TRAPID-AMI 研究）

2016-10-24

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

JCI：TRAP技术捕捉急性肾损伤的早期迹象

2015-03-08

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

NEJM：Dalcetrapib对近期有急性冠脉综合征的稳定性冠心病患者的疗效

2013-01-07

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

J Neurosci：spectraplakins蛋白或为治疗神经变性疾病提供新思路

2013-02-21

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

赛诺菲公司发布Zaltrap治疗肿瘤报告：喜忧参半

2012-12-31

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

赛诺菲及Regeneron抗癌药Zaltrap获FDA批准用于结直肠癌治疗

2013-06-25

xue8602 (审核中...)

前往app查看评论内容

#TRAP#

赛诺菲抗癌药Zaltrap 前列腺癌III期研究败北

2012-06-09

科室
- - 订阅+
  - 更多科室
工具
服务